drugset / Trial / NCT06614686
U87 CAR-T in Patients With Advanced Head and Neck Tumors
RandomizedSingle-groupOpen-labelTreatment
Summary
This is a single-arm, open-label clinical study to evaluate the safety, tolerability, and efficacy of U87 injection solution in patients with advanced malignant head and neck tumors.
Timeline
- Start
- 2024-09-20
- Primary completion
- 2026-10-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | U87 | Cell therapy | — | — |